Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Show Description +

Arshad M. Khanani, MD, MA, reviews the treatment discussions he has with diabetic retinopathy (DR) patients, while Nancy Holekamp, MD, describes how she tries to get patient buy-in.

Posted: 9/27/2018

Keywords:

Updates in Changing Treatment Paradigms for DR

Up Next in this Program

Name: Anti-VEGF for DR: Implications for Clinical Practice
Uploaded: 2018-09-27T10:02:00+00:00
Description: Arshad M. Khanani, MD, MA, reviews the treatment discussions he has with diabetic retinopathy (DR) patients, while Nancy Holekamp, MD, describes how she tries to get patient buy-in.

Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Updates in Changing Treatment Paradigms for DR

Translating Data for Educating Patients With DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Reviewing the BOULEVARD Trial and RG7716

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Think Outside the Box: Treatment Options for DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Key Takeaways for Treating Patients With DR

Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

How to Manage Patient Buy-In for Anti-VEGF Therapy

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Take-Home Points From the BOULEVARD Trial

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

New Horizons for Treatment Options for DR

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Medical Management of DR: Case Discussions

Kiss Case: Anti-VEGF Agents in a Case of PDR

Caroline R. Baumal, MD, Charles C. Wykoff, MD, PhD, FACS, Szilard Kiss, MD

Chiang Case: Peripheral Neovascularization With PDR

Allen Chiang, MD, Charles C. Wykoff, MD, PhD, FACS, Joseph M. Coney, MD

Coney Cases: Laser Versus Anti-VEGF Treatment for Diabetic Patients

Allen Chiang, MD, Charles Fritch MD, Joseph M. Coney, MD

Baumal Case: How to Treat Active PDR Without DME

Back to All Videos

Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Arshad M. Khanani, MD, MA, reviews the treatment discussions he has with diabetic retinopathy (DR) patients, while Nancy Holekamp, MD, describes how she tries to get patient buy-in.

Posted: 9/27/2018

Keywords:

Updates in Changing Treatment Paradigms for DR

Please log in to leave a comment.

Editorial Feature:

Diabetic Retinopathy

Anti-VEGF for DR: Implications for Clinical Practice

Up Next in this Program

Updates in Changing Treatment Paradigms for DR

Key Takeaways for Treating Patients With DR

Medical Management of DR: Case Discussions

Anti-VEGF for DR: Implications for Clinical Practice